To include your compound in the COVID-19 Resource Center, submit it here.

Xiaflex collagenase clostridium histolyticum: Phase II data

Top-line data from an open-label, dose-escalation, U.S. Phase II trial in 14 lipoma patients showed that a single injection of Xiaflex met the primary endpoint of actively reducing the visible surface area of the lipoma as measured

Read the full 376 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers